{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:55:25Z","timestamp":1791618925427,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Three New Project of Affiliated Yijishan Hospital of Wannan Medical College","award":["Y24061"],"award-info":[{"award-number":["Y24061"]}]},{"name":"Wannan Medical College Young and Middle aged Research Fund","award":["WK2024ZQNZ41"],"award-info":[{"award-number":["WK2024ZQNZ41"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cognitive impairment (CI) is common among end-stage renal disease (ESRD) patients undergoing maintenance hemodialysis (MHD), yet its relationship with hemoglobin levels remains underexplored. This study aimed to investigate the association between hemoglobin levels and CI in MHD patients, as well as to identify other contributing factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A cross-sectional study was conducted with 248 MHD patients (49.60% male, mean age 57.23\u2009\u00b1\u200913.16 years) from a single hemodialysis center. Cognitive function was assessed using the Mini-Mental State Examination (MMSE) with CI defined as a score\u2009&lt;\u200924. Hemoglobin levels were divided into quartiles (Q1: &lt; 90\u00a0g\/L; Q2: 90\u2013110\u00a0g\/L; Q3: 110\u2013130\u00a0g\/L; Q4: &gt;130\u00a0g\/L). Various independent variables, including age, sex, education level, dialysis duration, comorbidities, and laboratory parameters were analyzed using Spearman correlation test, and univariate and multivariate regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 248 patients, 33.90% (84 patients) had CI. Higher hemoglobin quartiles (Q3\/Q4) were associated with better cognitive function (higher MMSE scores, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and improved performance across cognitive domains. The Spearman and logistic regression analyses revealed the potential associations between cognitive function (MMSE scores) and several factors, including age, education level, dialysis duration, comorbidities, pre-dialysis blood pressure, interdialytic hypotension, albumin, creatinine, uric acid, and hemoglobin (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Age (OR\u2009=\u20091.454, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), male sex (OR\u2009=\u20090.171, <jats:italic>P<\/jats:italic>\u2009=\u20090.013), pre-dialysis diastolic blood pressure (OR\u2009=\u20090.884, <jats:italic>P<\/jats:italic>\u2009=\u20090.024), and uric acid (OR\u2009=\u20090.992, <jats:italic>P<\/jats:italic>\u2009=\u20090.007) were significantly linked with the presence of CI in MHD patients. Multivariate regression further confirmed that adequate hemoglobin concentration was an independent related factor against CI in MHD patients (Model 4, Q1 vs. Q3: OR\u2009=\u200915.395, 95% CI\u2009=\u20093.184\u201374.443, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Anemia is significantly associated with CI in MHD patients, and can still serve as a clinical marker for early detection and intervention in CI. Maintaining adequate hemoglobin levels may be linked with a reduced CI occurrence in hemodialysis patients. These findings highlight the importance of anemia management and tailored interventions to preserve cognitive function health in ESRD patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial number<\/jats:title>\n            <jats:p>Not applicable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04336-4","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T01:58:05Z","timestamp":1752544685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association of anemia and cognitive impairment in patients undergoing maintenance hemodialysis: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Lin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"4336_CR1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/17437199.2022.2132980","volume":"17","author":"FHF Chan","year":"2023","unstructured":"Chan FHF, Goh ZS, Zhu X, et al. Subjective cognitive complaints in end-stage renal disease: a systematic review and meta-analysis. Health Psychol Rev. 2023;17:614\u201340.","journal-title":"Health Psychol Rev"},{"key":"4336_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","volume":"63","author":"LA Inker","year":"2014","unstructured":"Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713\u201335.","journal-title":"Am J Kidney Dis"},{"key":"4336_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/diagnostics10040245","volume":"10","author":"L Cotoi","year":"2020","unstructured":"Cotoi L, Borcan F, Sporea I, et al. Thyroid pathology in end-stage renal disease patients on Hemodialysis. Diagnostics. 2020;10:245.","journal-title":"Diagnostics"},{"key":"4336_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1053\/j.ajkd.2020.03.028","volume":"76","author":"ML Mendu","year":"2020","unstructured":"Mendu ML, Weiner DE. Health policy and kidney care in the united states: core curriculum 2020. Am J Kidney Dis. 2020;76:720\u201330.","journal-title":"Am J Kidney Dis"},{"key":"4336_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/nu10010069","volume":"10","author":"M Maraj","year":"2018","unstructured":"Maraj M, Kusnierz-Cabala B, Dumnicka P, et al. Malnutrition, inflammation, atherosclerosis syndrome (MIA) and diet recommendations among end-stage renal disease patients treated with maintenance Hemodialysis. Nutrients. 2018;10:69.","journal-title":"Nutrients"},{"key":"4336_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s11920-012-0291-x","volume":"14","author":"YE Geda","year":"2012","unstructured":"Geda YE. Mild cognitive impairment in older adults. Curr Psychiat Rep. 2012;14:320\u20137.","journal-title":"Curr Psychiat Rep"},{"key":"4336_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/WAD.0b013e3182769731","volume":"28","author":"M Malek-Ahmadi","year":"2014","unstructured":"Malek-Ahmadi M, Davis K, Belden CM, et al. Comparative analysis of the alzheimer questionnaire (AQ) with the CDR sum of boxes, moca, and MMSE. Alzheimers Dis Assoc Dis. 2014;28:296\u20138.","journal-title":"Alzheimers Dis Assoc Dis"},{"key":"4336_CR8","doi-asserted-by":"publisher","first-page":"657794","DOI":"10.3389\/fnagi.2021.657794","volume":"13","author":"YC Hou","year":"2021","unstructured":"Hou YC, Huang CL, Lu CL, et al. The role of plasma neurofilament light protein for assessing cognitive impairment in patients with end-stage renal disease. Front Aging Neurosci. 2021;13:657794.","journal-title":"Front Aging Neurosci"},{"key":"4336_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jocn.2019.08.073","volume":"69","author":"G Vinothkumar","year":"2019","unstructured":"Vinothkumar G, Krishnakumar S, Venkataraman P. Correlation between abnormal GSK3\u03b2, \u03b2 amyloid, total tau, p-Tau 181 levels and neuropsychological assessment total scores in CKD patients with cognitive dysfunction: impact of rHuEPO therapy. J Clin Neurosci. 2019;69:38\u201342.","journal-title":"J Clin Neurosci"},{"key":"4336_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-019-0486-z","volume":"11","author":"YT Kuo","year":"2019","unstructured":"Kuo YT, Li CY, Sung JM, et al. Risk of dementia in patients with end-stage renal disease under maintenance dialysis-a nationwide population-based study with consideration of competing risk of mortality. Alzheimers Res Ther. 2019;11:31.","journal-title":"Alzheimers Res Ther"},{"key":"4336_CR11","doi-asserted-by":"publisher","first-page":"e01542","DOI":"10.1002\/brb3.1542","volume":"10","author":"J Zhang","year":"2020","unstructured":"Zhang J, Tang LJ, Hu J, et al. Uric acid is associated with cognitive impairment in the elderly patients receiving maintenance hemodialysis\u2014a two-center study. Brain Behav. 2020;10:e01542.","journal-title":"Brain Behav"},{"key":"4336_CR12","doi-asserted-by":"publisher","first-page":"e0175475","DOI":"10.1371\/journal.pone.0175475","volume":"12","author":"TB Chen","year":"2017","unstructured":"Chen TB, Yiao SY, Sun Y, et al. Comorbidity and dementia: a nationwide survey in Taiwan. PLoS ONE. 2017;12:e0175475.","journal-title":"PLoS ONE"},{"issue":"9","key":"4336_CR13","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.3109\/0886022X.2013.819768","volume":"35","author":"A Dixit","year":"2013","unstructured":"Dixit A, Dhawan S, Raizada A, et al. Attention and information processing in end stage renal disease and effect of hemodialysis: a bedside study. Ren Fail. 2013;35(9):1246\u201350.","journal-title":"Ren Fail"},{"key":"4336_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1113\/JP279237","volume":"598","author":"J Duffin","year":"2020","unstructured":"Duffin J, Hare GMT, Fisher JA. A mathematical model of cerebral blood flow control in anaemia and hypoxia. J Physiol-London. 2020;598:717\u201330.","journal-title":"J Physiol-London"},{"key":"4336_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10863-009-9247-1","volume":"41","author":"C Carvalho","year":"2009","unstructured":"Carvalho C, Correia SC, Santos RX, et al. Role of mitochondrial-mediated signaling pathways in alzheimer disease and hypoxia. J Bioenerg Biomembr. 2009;41:433\u201340.","journal-title":"J Bioenerg Biomembr"},{"key":"4336_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/13607863.2013.823375","volume":"18","author":"W Fadili","year":"2014","unstructured":"Fadili W, Al Adlouni A, Louhab N, et al. Prevalence and risk factors of cognitive dysfunction in chronic Hemodialysis patients. Aging Ment Health. 2014;18:207\u201311.","journal-title":"Aging Ment Health"},{"key":"4336_CR17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1053\/j.ajkd.2011.12.029","volume":"60","author":"EP Sorensen","year":"2012","unstructured":"Sorensen EP, Sarnak MJ, Tighiouart H, et al. The kidney disease quality of life cognitive function subscale and cognitive performance in maintenance Hemodialysis patients. Am J Kidney Dis. 2012;60:417\u201326.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"4336_CR18","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1053\/j.ajkd.2015.12.028","volume":"67","author":"E O\u2019Lone","year":"2016","unstructured":"O\u2019Lone E, Connors M, Masson P, et al. Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2016;67(6):925\u201335.","journal-title":"Am J Kidney Dis"},{"key":"4336_CR19","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1053\/j.ajkd.2019.05.017","volume":"74","author":"DA Drew","year":"2019","unstructured":"Drew DA, Weiner DE, Sarnak MJ. Cognitive impairment in CKD: pathophysiology, management, and prevention. Am J Kidney Dis. 2019;74:782\u201390.","journal-title":"Am J Kidney Dis"},{"key":"4336_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2459\/JCM.0000000000000005","volume":"15","author":"G Pulignano","year":"2014","unstructured":"Pulignano G, Del Sindaco D, Di Lenarda A, et al. Chronic renal dysfunction and anaemia are associated with cognitive impairment in older patients with heart failure. J Cardiovasc Med. 2014;15:481\u201390.","journal-title":"J Cardiovasc Med"},{"key":"4336_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12883-023-03407-z","volume":"23","author":"D Chen","year":"2023","unstructured":"Chen D, Xiao C, Xiao WY, et al. Prediction model for cognitive impairment in maintenance Hemodialysis patients. BMC Neurol. 2023;23:367.","journal-title":"BMC Neurol"},{"key":"4336_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00127893-200305000-00001","volume":"9","author":"C De Carli","year":"2003","unstructured":"De Carli C. The role of cerebrovascular disease in dementia. Neurologist. 2003;9:123\u201336.","journal-title":"Neurologist"},{"key":"4336_CR23","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1053\/j.ajkd.2004.10.024","volume":"45","author":"AA Pereira","year":"2005","unstructured":"Pereira AA, Weiner DE, Scott T, et al. Cognitive function in dialysis patients. Am J Kidney Dis. 2005;45:448\u201362.","journal-title":"Am J Kidney Dis"},{"key":"4336_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neuro.2014.06.014","volume":"44","author":"K Watanabe","year":"2014","unstructured":"Watanabe K, Watanabe T, Nakayama M. Cerebro-renal interactions: impact of uremic toxins on cognitive function. Neurotoxicology. 2014;44:184\u201393.","journal-title":"Neurotoxicology"},{"key":"4336_CR25","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1681\/ASN.2013101086","volume":"26","author":"MT Eldehni","year":"2015","unstructured":"Eldehni MT, Odudu A, Mcintyre CW. Randomized clinical trial of dialysate cooling and effects on brain white matter. J Am Soc Nephrol. 2015;26:957\u201365.","journal-title":"J Am Soc Nephrol"},{"key":"4336_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/CIA.S178854","volume":"14","author":"XH Pei","year":"2019","unstructured":"Pei XH, Lai SY, He XL, et al. Mild cognitive impairment in maintenance Hemodialysis patients: a cross-sectional survey and cohort study. Clin Interv Aging. 2019;14:27\u201332.","journal-title":"Clin Interv Aging"},{"issue":"2","key":"4336_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/sdi.13017","volume":"35","author":"HH Xiao","year":"2022","unstructured":"Xiao HH, Li H, Dong LP, et al. Correlation between home systolic blood pressure variability and cognitive impairment in maintenance Hemodialysis patients. Semin Dialysis. 2022;35(2):129\u201337.","journal-title":"Semin Dialysis"},{"issue":"6","key":"4336_CR28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/15257770802138558","volume":"27","author":"YY Sautin","year":"2008","unstructured":"Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleos Nucleot Nucl. 2008;27(6):608\u201319.","journal-title":"Nucleos Nucleot Nucl"},{"issue":"3","key":"4336_CR29","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3233\/JAD-142037","volume":"44","author":"E Al-khateeb","year":"2015","unstructured":"Al-khateeb E, Althaher A, Al-khateeb M, et al. Relation between uric acid and alzheimer\u2019s disease in elderly Jordanians. J Alzheimers Dis. 2015;44(3):859\u201365.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"4336_CR30","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3233\/JAD-160028","volume":"52","author":"MA Beydoun","year":"2016","unstructured":"Beydoun MA, Canas JA, Dore GA, et al. Serum uric acid and its association with longitudinal cognitive change among urban adults. J Alzheimers Dis. 2016;52(4):1415\u201330.","journal-title":"J Alzheimers Dis"},{"key":"4336_CR31","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.2147\/NDT.S380518","volume":"18","author":"XL Tian","year":"2022","unstructured":"Tian XL, Xia XS, Yu HB, et al. Cognitive dysfunction and its risk factors in patients undergoing maintenance Hemodialysis. Neuropsych Dis Treat. 2022;18:2759\u201369.","journal-title":"Neuropsych Dis Treat"},{"key":"4336_CR32","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1038\/s41598-018-37935-3","volume":"9","author":"MK Mazumder","year":"2019","unstructured":"Mazumder MK, Paul R, Bhattacharya P, et al. Neurological sequel of chronic kidney disease: from diminished acetylcholinesterase activity to mitochondrial dysfunctions, oxidative stress and inflammation in mice brain. Sci Rep. 2019;9:3097.","journal-title":"Sci Rep"},{"key":"4336_CR33","doi-asserted-by":"publisher","first-page":"2217276","DOI":"10.1080\/0886022X.2023.2217276","volume":"45","author":"Q Sun","year":"2023","unstructured":"Sun Q, Zheng JH, Zhang YT, et al. Altered spontaneous brain activities in maintenance Hemodialysis patients with cognitive impairment and the construction of cognitive function prediction models. Ren Fail. 2023;45:2217276.","journal-title":"Ren Fail"},{"key":"4336_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.nrl.2017.07.016","volume":"35","author":"EE Reza-Zald\u00edvar","year":"2020","unstructured":"Reza-Zald\u00edvar EE, Sandoval-Avila S, Guti\u00e9rrez-Mercado YK, et al. Human Recombinant erythropoietin reduces sensorimotor dysfunction and cognitive impairment in rat models of chronic kidney disease. Neurologia. 2020;35:147\u201354.","journal-title":"Neurologia"},{"key":"4336_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12882-016-0347-y","volume":"17","author":"MK Tamura","year":"2016","unstructured":"Tamura MK, Vittinghoff E, Yang JR, et al. Anemia and risk for cognitive decline in chronic kidney disease. BMC Nephrol. 2016;17:131\u20137.","journal-title":"BMC Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04336-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04336-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04336-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T09:47:42Z","timestamp":1757238462000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04336-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4336"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04336-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this research in accordance with the Declaration of Helsinki was acquired from the Ethics Committee of Wannan Medical College Affiliated Yijishan Hospital (Approved number. 20240326), and the written informed consent was obtained from all participants involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants have given consent for their anonymous quotes and anonymised transcripts of their interactions to be used in publications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"387"}}